Read about the latest advances from the Lady Davis Institute for Medical Research (LDI) and its researchers, including new findings, grant awards, innovations, and collaborations.
Family history and age, not ancestry, influence decisions to decline genetic testing after breast cancer diagnosis
Women newly diagnosed with breast cancer who declined genetic testing were more likely to be older and have no family history of cancer, according to a new cross-sectional study from the Lady Davis Institute for Medical Research (LDI) and McGill University.
Lady Davis Institute for Medical Research investigators awarded more than $12.9M from CIHR
Twelve research teams from the LDI were awarded $12,903,057 in combined funding through the Canadian Institutes of Health Research (CIHR) Fall 2025 Project Grant and Team Grants: Bringing Biology to Cancer Prevention competitions.
Cutting-edge study highlights the role of a new blood test that may help decide who needs chemotherapy in patients with aggressive breast cancer
The research provides new insights into the prognostic value of ctDNA and its ability to guide personalized treatment strategies for patients with triple-negative breast cancer.
